Form 4: Boston Scientific Director Charles J. Dockendorff Receives Equity Award

Director Charles J. Dockendorff received 2,901 shares of Boston Scientific Corp. stock as an annual equity award.

Summary

• On May 9, 2024, Charles J. Dockendorff, a director of Boston Scientific Corp., acquired 2,901 shares of common stock as an annual equity award.
• The shares were granted at a price of $0.0000 per share.
• Following the transaction, Dockendorff directly owns 2,901 shares of common stock.
• Dockendorff also indirectly owns 42,622 shares through a spouse's trust and 17,380 shares through another trust.

Sentiment

Score: 7

Explanation: The document reflects a routine equity award, which is generally viewed positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The equity award aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company.

Future Outlook

The equity award vests upon the next annual meeting of stockholders, incentivizing continued service.

Industry Context

Equity awards are a common form of compensation for directors in publicly traded companies, aligning their interests with those of shareholders and incentivizing company performance.

Comparison to Industry Standards

• Equity awards for directors vary significantly based on company size, performance, and industry.
• Comparing the $215,000 equity award to similar companies in the medical device industry would provide a benchmark for assessing its relative value.
• Companies like Medtronic, Abbott Laboratories, and Stryker are comparable in size and scope to Boston Scientific and offer similar equity-based compensation to their directors.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term performance.
• The award does not have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

• The shares will vest upon the next annual meeting of stockholders.

Key Dates